Zhitong Finance App News, Xiansheng Pharmaceutical (02096) announced that Mr. Wan Yushan (Mr. Wan) will no longer serve as the Company's Joint Company Secretary (Joint Company Secretary), effective August 20, 2026. Mr. Wan will continue to serve as the Company's Executive Director and Chief Financial Officer.

The board of directors further announced that Mr. Zhu Da (Mr. Zhu), the current secretary of the board of directors of the Company, has been appointed concurrently as the Joint Company Secretary to replace Mr. Wan, effective from August 20, 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.